Stay updated on Daratumumab in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated metadata with new date entries and the topic tag for Multiple myeloma; removed several old date stamps and the plain 'Last Update Posted' label. Overall, metadata and topic tagging were expanded while some older timestamps were cleaned up.
    Difference
    0.7%
    Check dated 2025-10-13T11:55:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    - Added a government funding notice and current NIH Clinical Center operating status, plus a v3.2.0 revision tag. - Removed the older MedlinePlus Genetics topic: Multiple myeloma and old revision tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T06:59:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Core terminology updated: 'Plasma cell myeloma' replaced with 'Multiple myeloma'; page version updated from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T03:47:05.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, with no substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T21:45:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.4%
    Check dated 2025-09-07T18:14:53.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a range of new medical and chemical terms related to plasma cell myeloma and its treatment. Notably, several previous terms and topics related to multiple myeloma and various drug classifications have been removed.
    Difference
    5%
    Check dated 2025-08-31T12:24:07.000Z thumbnail image

Stay in the know with updates to Daratumumab in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Newly Diagnosed Multiple Myeloma Clinical Trial page.